{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T12:45:45Z","timestamp":1785156345428,"version":"3.55.0"},"reference-count":36,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2016,3,17]],"date-time":"2016-03-17T00:00:00Z","timestamp":1458172800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0151809","type":"journal-article","created":{"date-parts":[[2016,3,17]],"date-time":"2016-03-17T17:54:20Z","timestamp":1458237260000},"page":"e0151809","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":30,"title":["Metabolic Tumour Burden Measured by 18F-FDG PET\/CT Predicts Malignant Transformation in Patients with Neurofibromatosis Type-1"],"prefix":"10.1371","volume":"11","author":[{"given":"Axel","family":"Van Der Gucht","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ouidad","family":"Zehou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soraya","family":"Djelbani-Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Valeyrie-Allanore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Ortonne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Brugi\u00e8res","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Wolkenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Luciani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Rahmouni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Sbidian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Itti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,3,17]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/jmg.2006.045906","article-title":"Guidelines for the diagnosis and management of individuals with neurofibromatosis 1","volume":"44","author":"RE Ferner","year":"2007","journal-title":"J Med Genet"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0748-7983(05)80073-3","article-title":"Malignant peripheral nerve sheath tumors in patients with and without neurofibromatosis","volume":"21","author":"PF Doorn","year":"1995","journal-title":"Eur J Surg Oncol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1750-1172-6-18","article-title":"Mortality associated with neurofibromatosis 1: a cohort study of 1895 patients in 1980\u20132006 in France","volume":"6","author":"TA Duong","year":"2011","journal-title":"Orphanet J Rare Dis"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1136\/jmg.39.5.311","article-title":"Malignant peripheral nerve sheath tumours in neurofibromatosis 1","volume":"39","author":"DGR Evans","year":"2002","journal-title":"J Med Genet"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1086\/320121","article-title":"Mortality in neurofibromatosis 1: an analysis using U.S. death certificates","volume":"68","author":"SA Rasmussen","year":"2001","journal-title":"Am J Hum Genet"},{"key":"ref6","first-page":"1573","article-title":"International consensus statement on malignant peripheral nerve sheath tumors in neurofibromatosis","volume":"62","author":"RE Ferner","year":"2002","journal-title":"Cancer Res"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s00432-008-0523-y","article-title":"Differentiation between neurofibromas and malignant peripheral nerve sheath tumors in neurofibromatosis 1 evaluated by MRI","volume":"135","author":"A Matsumine","year":"2009","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.2214\/AJR.09.2724","article-title":"MRI features in the differentiation of malignant peripheral nerve sheath tumors and neurofibromas","volume":"194","author":"J Wasa","year":"2010","journal-title":"AJR Am J Roentgenol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1038\/jid.2010.100","article-title":"NF-1 Score: a prediction score for internal neurofibromas in neurofibromatosis-1","volume":"130","author":"E Sbidian","year":"2010","journal-title":"J Invest Dermatol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1750-1172-6-51","article-title":"At-risk phenotype of neurofibromatose-1 patients: a multicentre case-control study","volume":"6","author":"E Sbidian","year":"2011","journal-title":"Orphanet J Rare Dis"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1111\/j.1365-2133.2008.08494.x","article-title":"Histopathologically dysplastic neurofibromas in neurofibromatosis 1: diagnostic criteria, prevalence and clinical significance","volume":"158","author":"L Valeyrie-Allanore","year":"2008","journal-title":"Br J Dermatol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.2967\/jnumed.109.074229","article-title":"Correlation between glycolytic phenotype and tumor grade in soft-tissue sarcomas by 18F-FDG PET","volume":"51","author":"MR Benz","year":"2010","journal-title":"J Nucl Med"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s00259-008-1038-0","article-title":"[18F]FDG PET\/CT in the diagnosis of malignant peripheral nerve sheath tumours in neurofibromatosis type-1","volume":"36","author":"VS Warbey","year":"2009","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"A160","DOI":"10.1227\/01.NEU.0000337597.18599.D3","article-title":"Potential role of 18fluorodeoxyglucose-positron emission tomography\/computed tomography in differentiating benign neurofibroma from malignant peripheral nerve sheath tumor associated with neurofibromatosis 1","volume":"65","author":"K Karabatsou","year":"2009","journal-title":"Neurosurgery"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1097\/RLU.0b013e318266ce84","article-title":"Comparative effectiveness of 18F-FDG PET\/CT versus whole-body MRI for detection of malignant peripheral nerve sheath tumors in neurofibromatosis type 1","volume":"38","author":"T Derlin","year":"2013","journal-title":"Clin Nucl Med"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1093\/annonc\/mdm450","article-title":"[18F]2-fluoro-2-deoxy-D-glucose positron emission tomography (FDG PET) as a diagnostic tool for neurofibromatosis 1 (NF1) associated malignant peripheral nerve sheath tumours (MPNSTs): a long-term clinical study","volume":"19","author":"RE Ferner","year":"2008","journal-title":"Ann Oncol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s00259-012-2314-6","article-title":"Evaluation of intratumoural heterogeneity on <sup>18<\/sup>F-FDG PET\/CT for characterization of peripheral nerve sheath tumours in neurofibromatosis type 1","volume":"40","author":"J Salamon","year":"2013","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"e85954","DOI":"10.1371\/journal.pone.0085954","article-title":"Utility of 18F-FDG PET with a semi-quantitative index in the detection of sarcomatous transformation in patients with neurofibromatosis type 1","volume":"9","author":"P Combemale","year":"2014","journal-title":"PloS One"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00330-013-3020-x","article-title":"18F-FDG PET\/CT for detection of malignant peripheral nerve sheath tumours in neurofibromatosis type 1: tumour-to-liver ratio is superior to an SUVmax cut-off","volume":"24","author":"J Salamon","year":"2014","journal-title":"Eur Radiol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"379","DOI":"10.2967\/jnumed.114.142372","article-title":"18F-FDG PET\/CT qualitative and quantitative evaluation in neurofibromatosis type 1 patients for detection of malignant transformation: comparison of early to delayed imaging with and without liver activity normalization","volume":"56","author":"A Chirindel","year":"2015","journal-title":"J Nucl Med"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S1095-0397(99)00016-3","article-title":"Tumor Treatment Response Based on Visual and Quantitative Changes in Global Tumor Glycolysis Using PET-FDG Imaging. The Visual Response Score and the Change in Total Lesion Glycolysis","volume":"2","author":"SM Larson","year":"1999","journal-title":"Clin Positron Imaging"},{"key":"ref22","first-page":"1808","article-title":"18F-FDG PET definition of gross tumor volume for radiotherapy of non-small cell lung cancer: is a single standardized uptake value threshold approach appropriate?","volume":"47","author":"KJ Biehl","year":"2006","journal-title":"J Nucl Med"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.acra.2012.07.002","article-title":"Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer","volume":"20","author":"H Zhang","year":"2013","journal-title":"Acad Radiol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.ijrobp.2008.10.060","article-title":"Metabolic tumor volume predicts for recurrence and death in head-and-neck cancer","volume":"74","author":"TH La","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1245\/s10434-011-2153-x","article-title":"Prognostic value of preoperative metabolic tumor volume and total lesion glycolysis in patients with epithelial ovarian cancer","volume":"19","author":"HH Chung","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1007\/s00259-013-2511-y","article-title":"Total lesion glycolysis by 18F-FDG PET\/CT is a reliable predictor of prognosis in soft-tissue sarcoma","volume":"40","author":"E-S Choi","year":"2013","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1007\/s00259-014-2756-0","article-title":"The value of <sup>18<\/sup>F-FDG PET\/CT in the management of malignant peripheral nerve sheath tumors","volume":"41","author":"B Khiewvan","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1001\/archneur.1988.00520290115023","article-title":"Neurofibromatosis. Conference statement. National Institutes of Health Consensus Development Conference","volume":"45","year":"1988","journal-title":"Arch Neurol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1007\/s00259-014-2705-y","article-title":"Metabolic tumour volumes measured at staging in lymphoma: methodological evaluation on phantom experiments and patients","volume":"41","author":"M Meignan","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s00259-014-2961-x","article-title":"FDG PET\/CT: EANM procedure guidelines for tumour imaging: version 2.0","volume":"42","author":"R Boellaard","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1007\/s00259-005-0030-1","article-title":"Prognostic relevance of FDG PET in patients with neurofibromatosis type-1 and malignant peripheral nerve sheath tumours","volume":"33","author":"W Brenner","year":"2006","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00259-011-1936-4","article-title":"Prediction of tumour necrosis fractions using metabolic and volumetric 18F-FDG PET\/CT indices, after one course and at the completion of neoadjuvant chemotherapy, in children and young adults with osteosarcoma","volume":"39","author":"HJ Im","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0140-6736(04)15433-0","article-title":"Risk of cancer from diagnostic X-rays: estimates for the UK and 14 other countries","volume":"363","author":"A Berrington de Gonz\u00e1lez","year":"2004","journal-title":"Lancet Lond Engl"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1148\/radiol.2511080671","article-title":"The Linear No-Threshold Relationship Is Inconsistent with Radiation Biologic and Experimental Data","volume":"251","author":"M Tubiana","year":"2009","journal-title":"Radiology"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1007\/s00259-014-2783-x","article-title":"Baseline metabolic tumour volume is an independent prognostic factor in Hodgkin lymphoma","volume":"41","author":"S Kanoun","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1007\/s00259-014-2822-7","article-title":"Pretherapy metabolic tumour volume is an independent predictor of outcome in patients with diffuse large B-cell lymphoma","volume":"41","author":"M Sasanelli","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0151809","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,24]],"date-time":"2018-10-24T04:18:14Z","timestamp":1540354694000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0151809"}},"subtitle":[],"editor":[{"given":"Pirkko L.","family":"H\u00e4rk\u00f6nen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,3,17]]},"references-count":36,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2016,3,17]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0151809","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,17]]}}}